Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05592457
Other study ID # MDCT in ESWL
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 15, 2022
Est. completion date October 30, 2024

Study information

Verified date October 2022
Source Assiut University
Contact Dina Essam, resident
Phone 01027664829
Email Dina.14224214@med.aun.edu.eg
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Urinary stones are a common disease affecting one in 11 people . Their clinical presentation varies from being silent to severe loin pain owing to urinary obstruction. Currently, ESWL is the treatment of choice for most renal calculi ⩽30 mm, with success rates of 60-99%. Although many treatment options exist, ESWL has the advantages of simplicity and non-invasiveness. In contrast, failure of a first ESWL attempt requires a follow-up ESWL procedure, or an alternative procedure, both of which increase medical costs. Advancements in imaging have significantly contributed to this process. In the mid- 1990s, computed tomography (CT) began to replace intravenous urography (IVU), abdominal films (KUB), and ultrasound (US) in stone diagnosis. Studies demonstrated that CT had superior sensitivity and specificity for stone diagnosis compared to the aforementioned modalities. Now non-contrast multidetector CT (NC-MDCT) is the gold standard for the detection of urinary system calculi. CT is also clinically useful as it can show alternate renal and non-renal pathology if present. Many factors have been reported to predict ESWL outcome, such as skin-to-stone distance (SSD), stone size, stone location, multiplicity, the energy used, and Hounsfield Unit (HU) values measured by non-contrast computed tomography (NCCT).


Description:

Excellent fragmentation results are produced using ESWL. However, the retention of post-ESWL fragments in the kidney continues to be a significant medical issue. Only 32% of calcium stone patients in research were found to remain stone-free for 12 months following ESWL, according to the results. As a result, it appears that fragment growth and persistence are frequent after ESWL [10]. The first ESWL residual that is accessible must undergo a thorough stone analysis to properly carry out the subsequent treatments to prevent relapse or recurrent stone because stone-free rates after ESWL are directly connected to stone placement, size, number, and composition


Recruitment information / eligibility

Status Recruiting
Enrollment 55
Est. completion date October 30, 2024
Est. primary completion date October 30, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - patients older than 18 years. - stone size up to 25 mm for renal pelvic stones and up to 15 mm for upper ureteric stones. - SSD < 11 cm. Exclusion Criteria: - any patient with contraindications to ESWL as - uncontrolled urinary infection. - clotting alterations. - aortic or renal artery aneurysm. - pregnancy. - serious skeletal malformations. - serious obesity and or contraindications to CT as pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
MSCT
multislice computed tomography

Locations

Country Name City State
Egypt Assiut University Hospital Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Johnson EK, Faerber GJ, Roberts WW, Wolf JS Jr, Park JM, Bloom DA, Wan J. Are stone protocol computed tomography scans mandatory for children with suspected urinary calculi? Urology. 2011 Sep;78(3):662-6. doi: 10.1016/j.urology.2011.02.062. Epub 2011 Jun 30. — View Citation

Rassweiler JJ, Renner C, Chaussy C, Thüroff S. Treatment of renal stones by extracorporeal shockwave lithotripsy: an update. Eur Urol. 2001 Feb;39(2):187-99. Review. — View Citation

Weld KJ, Montiglio C, Morris MS, Bush AC, Cespedes RD. Shock wave lithotripsy success for renal stones based on patient and stone computed tomography characteristics. Urology. 2007 Dec;70(6):1043-6; discussion 1046-7. — View Citation

Wolf JS Jr, Clayman RV. Percutaneous nephrostolithotomy. What is its role in 1997? Urol Clin North Am. 1997 Feb;24(1):43-58. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary ct follow up during swl Correlation between the stone density before and during ESWL sessions to determine if this predicts the success prevent new ESWL. 3 weeks
Primary stone Hounsfield Determine the role of the density of the residual stone fragments in the prediction of the complication during ESWL. 3weeks
Secondary density of stone and other factors Correlate between stone density and other factors in the prediction of the success of ESWL. 3weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04846465 - Femoral Neck-shaft Angle in Sohag Population
Recruiting NCT04924790 - The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions
Completed NCT04697706 - Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease Early Phase 1
Not yet recruiting NCT02949323 - Etiological Diagnosis of Urinary Stone in Chinese Children N/A
Recruiting NCT06083051 - Differences in Postoperative Symptoms With Four Ureteral Stents N/A
Recruiting NCT03846011 - Comparison of 24-hour Collecting Urine Prior and After Stone Removal
Completed NCT04112160 - Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal Phase 2
Recruiting NCT03108053 - Results of Safety Guidewire Use in Ureteroscopic Stone Surgery N/A
Terminated NCT03195920 - Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease N/A
Completed NCT04594161 - Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis N/A
Not yet recruiting NCT04796792 - Ultrasound to Facilitate Stone Passage N/A
Completed NCT04387617 - A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones Phase 2/Phase 3
Terminated NCT03339388 - Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease N/A
Recruiting NCT04598971 - Urine pH and Urinary Tract Infection